Parexel has trimmed back its earnings guidance for the first quarter of fiscal 2009 as it starts the process of integrating ClinPhone, which the company bought for £91m (€114m) last month.
Beleaguered life science tools and services company MDS Inc, has recorded disappointing third quarter results, with revenues from its Analytical Technologies and MDS Pharma Services divisions missing forecasts.
eClinical specialist Phase Forward has added to its portfolio by purchasing interactive-response technology company Clarix for $40m in cash in a move aimed at toppling ClinPhone from its leading position in the sector.
ICON has introduced an electronic Patient Recorded Outcomes (ePRO) module that could slash weeks off the time it takes to implement the technology in clinical trials.
IT infrastructure and business process services firm Cognizant has cut back its full-year financial forecasts on signs that the downturn in the economy is starting to bite at some of its major clients, particularly those in the healthcare sector.
Outsourcing-Pharma.com provides its periodic round-up of developments in the eClinical space, including a tough decision for Datatrak, news of a new contract for Medidata , a recruitment package from HMS and cardiac data certification for specialty CRO...
Like many of its peers in the contract clinical research sector, data management specialist Phase Forward put in another bumper financial performance in the second quarter headed by a 30 per cent hike in revenues to $41m.
ClinPhone's shareholders have now approved the acquisition of the company by Parexel after rival Quintiles withdrew from the race to buy the eClinical technology company.
Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with senior appointments at Bristol-Myers Squibb, Parexel and GVK Bio, amongst others.
Pharmaceutical companies in the developed world have already
shifted substantial manufacturing and clinical trial work to
emerging economies such as China and India, but a new study suggest
they are increasingly counting on these...
Only months after having its first offer rejected, ClinPhone has
finally agreed to a deal allowing Parexel to acquire the firm.
However Quintiles has indicated it may make a play to outbid its
rival.
PharmaLinkFHI has announced the acquisition of a UK-based clinical
research organisation (CRO) called Matrix, as consolidation within
this industry sector continues.
IT infrastructure and business process services firm Cognizant has
announced an alliance with CTC Laboratory Systems that aims to
assist Japanese pharmaceutical firms in enhancing efficiencies in
drug discovery and development.
Overall, 2007 was another stellar year for contract service
providers, particularly those at the early-stage end of
development, although companies are advised to watch out for a
tougher environment ahead.
Cognizant is gaining ground in the life sciences arena, this week
inking a $95m data management deal with AstraZeneca, just three
months after sealing another multi-million dollar deal with Merck
& Co.
UK-based AstraZeneca has recently given the region's dominant
telecommunications provider, British Telecom (BT) a greater role in
its business, to the tune of £25m.
Japan's Eisai has inked a deal with Accenture to have it provide it
with global clinical data management services from India, and
becomes the first big Japanese pharma firm to take such a step.
Affiliated Computer Services (ACS) is on the receiving end of
Allergan's decision to outsource its IT functions, inking a $130m
contract with the specialty pharma firm.
Merck & Co. has just inked "multi-million dollar" deal
with Cognizant, at a time when the US-based IT services firm is
pursuing a greater presence in the life sciences sector.
As eClinical gathers momentum, Outsourcing-Pharma.com spoke to two
contract research organisations (CROs), Icon and Parexel, to get
their views on the present and future of these emerging
technologies.
GVK Bio has reinforced its claim to be India's top contract
research organisation with a 100-crore ($25m) push from a private
investment company. The funds will be used to expand its drug
discovery services and push further into...
Novo Nordisk is in the process of relocating its clinical data
management centre to India after closing down the operation in
Singapore, where it had been previously run for many years.
Indian IT firm Tata Consultancy Services (TCS) has bagged its
second high profile pharma outsourcing deal this year with a new
multi-year contract with Swiss drug maker Roche.
etrials and Clinphone, two big players in the eclinical industry
are struggling to keep their heads above water as both companies'
recent woes have impacted their bottom line.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Innovaderm
Research, Target Health, Qualia Clinical Service, and Quintiles.
In a round-up of motley pharmaceutical services news,
Outsourcing-Pharma takes a look at recent announcements involving
Quintiles, Kenexa, Atos, Catalent Pharma, Patni and Taratec.
Computer giant IBM has re-inked a huge $1.4bn (€1.0bn) IT
outsourcing deal with drug giant AstraZeneca, who is continuing its
cost-cutting drive to become 'lean and agile'.
The pharmaceutical and healthcare industries will help to push
trade between India and the United Kingdom up by 60 per cent within
three years, claims a soon-to-be released report.
Pfizer has shunned a more traditional approach to data management
outsourcing by slashing its vendors to a handful and standardising
them under the one business model.
Switzerland's Bobst has introduced a new system for embossing
Braille characters on pharmaceutical packaging that moves the
process down the production line from die-cutting to the folding
and gluing stage.
Octagon has bought an electronic data capture (EDC) company and is
now claiming to be the first company to address the process problem
in clinical R&D by offering "an end-to-end solution that
crosses traditional functional...
GlaxoSmithKline (GSK) has announced plans to outsource all its data
management and medical trial and regulatory reporting functions to
India in a deal said to be worth over £10m (€14.7m).
GlaxoSmithKline (GSK) has decided to consolidate all its human
resources business process outsourcing (BPO) services under the one
umbrella in a contract valued at $171m (€131m).
More companies in the pharmaceutical industry than any other
industry are set to increase their reliance on information
technology (IT) and business process (BP) outsourcing this year,
new research indicates.
The move towards electronic files is set to bring major benefits in
the clinical trials area especially in terms of patient
recruitment, new research suggests.
In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...
It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...